8-K
Current Report
Dianthus Therapeutics, Inc. /DE/ Filed Acc 0001193125-22-186149
Shareholder vote results
- Item 5.07 Submission of matters to a vote of security holders
From the SEC's structured data for this filing
Loading d364913d8k.htm…